These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals. Gorczynski RM J Immunol; 1974 May; 112(5):1826-38. PubMed ID: 4361978 [No Abstract] [Full Text] [Related]
6. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems. Law LW Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038 [No Abstract] [Full Text] [Related]
7. Studies of FBJ osteosarcoma virus in tissue culture. I. Biologic characteristics of the "C"-type viruses. Levy JA; Hartley JW; Rowe WP; Huebner RJ J Natl Cancer Inst; 1973 Aug; 51(2):525-39. PubMed ID: 4358136 [No Abstract] [Full Text] [Related]
8. Recovery of a hamster-specific, focus-forming, and sarcomagenic virus from a "noninfectious" hamster tumor induced by the Kirsten Mouse sarcoma virus. Klement V; Hartley JW; Rowe WP; Huebner RJ J Natl Cancer Inst; 1969 Oct; 43(4):925-34. PubMed ID: 4310099 [No Abstract] [Full Text] [Related]
9. Induction and inhibition of host immunity to experimental neoplasms. Discussion. Br J Cancer Suppl; 1973 Aug; 1():62-71. PubMed ID: 4804291 [No Abstract] [Full Text] [Related]
10. Murine virus contaminants of leukemia viruses and transplantable tumors. Collins MJ; Parker JC J Natl Cancer Inst; 1972 Oct; 49(4):1139-43. PubMed ID: 4343473 [No Abstract] [Full Text] [Related]
11. In vivo suppression of syngeneic murine fibrosarcoma by macrophages and lymphocytes. Gupta N; Aikat BK; Sehgal S Indian J Med Res; 1982 Apr; 75():583-9. PubMed ID: 7106899 [No Abstract] [Full Text] [Related]
12. [Current and prospective problems in tumor immunology]. Pitzurra M Boll Ist Sieroter Milan; 1971; 50(3):209-20. PubMed ID: 4947785 [No Abstract] [Full Text] [Related]
13. Inhibitory effect of immune serum on carcinogenesis in mice neonatally infected with murine sarcoma virus (Harvey). BubenÃk J; Turano A Folia Biol (Praha); 1968; 14(6):433-9. PubMed ID: 4303534 [No Abstract] [Full Text] [Related]
15. STUDIES ON SPECIFIC TRANSPLANTATION RESISTANCE TO POLYOMA-VIRUS-INDUCED TUMORS. II. MECHANISM OF RESISTANCE INDUCED BY POLYOMA VIRUS INFECTION. SJOEGREN HO J Natl Cancer Inst; 1964 Feb; 32():375-93. PubMed ID: 14120159 [No Abstract] [Full Text] [Related]
17. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice. Plata F; Gomard E; Leclerc JC; Levy JP J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862 [No Abstract] [Full Text] [Related]
18. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats. Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248 [No Abstract] [Full Text] [Related]
19. Histogenesis and Morphology of periosteal sarcomas induced by FBJ virus in NIH Swiss mice. Ward JM; Young DM Cancer Res; 1976 Nov; 36(11 Pt 1):3985-92. PubMed ID: 184921 [TBL] [Abstract][Full Text] [Related]
20. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation. Gorczynski RM J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977 [No Abstract] [Full Text] [Related] [Next] [New Search]